Comparison of a single half-dose, long-acting form of gonadotropin-releasing hormone analog (GnRH-a) and a short-acting form of GnRH-a for pituitary suppression in a controlled ovarian hyperstimulation program
Yy. Hsieh et al., Comparison of a single half-dose, long-acting form of gonadotropin-releasing hormone analog (GnRH-a) and a short-acting form of GnRH-a for pituitary suppression in a controlled ovarian hyperstimulation program, FERT STERIL, 73(4), 2000, pp. 817-820
Objective: To compare the effect of a single low-dose leuprolide acetate de
pot (LA depot) and leuprolide acetate (LA) on pituitary down-regulation in
women undergoing controlled ovarian hyperstimulation (COH).
Design: Retrospective study.
Setting: An IVF unit of an academic medical center.
Patient(s): Women who underwent COH and IVF-ET.
Intervention(s): Pituitary down-regulation with half-dose LA depot (1.88 mg
sc, group 1) or LA (0.5 mg/d sc, group 2) was started on menstrual days 21
-23.
Main Outcome Measure(s): The concentrations of estradiol (E-2), FSH, LH, go
nadotropin dosages, the numbers of oocytes retrieved, oocytes fertilized an
d embryos transferred, and pregnancy rates of the two groups were compared.
Result(s): A total of 289 patients in group 1 and 158 in group 2 were inclu
ded. There were no statistically significant differences between the two gr
oups in baseline concentrations of E-2 and FSH, concentrations of E-2, FSH,
and LH during hCG administration, gonadotropin dosage, the number of oocyt
es retrieved, the number of oocytes fertilized and embryos transferred, and
pregnancy rates.
Conclusion(s): Single half-dose LA depot offers a useful alternative for pi
tuitary suppression in ovarian stimulation for IVF. (C) 2000 by American So
ciety for Reproductive Medicine.